// App-Quantinova.ai

OC 04.5 : Immune Medicated Thrombotic Thrombocytopenic Purpura relapse is associated with HLA-DRB1*15:01

Researchers

Presenter

  • M. Stubbs

Principal Investigators

  • A. Doyle

  • A. Levine

  • M. Thomas

  • M. Scully

Medical Centers

  • University College London Hospitals NHS Trust, London, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Kings College London, London, United Kingdom

  • University College Hospitals London NHS Foundation Trust, London, England, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Blood/haematological Diseases

Disease

  • Thrombotic thrombocytopenic purpura

Biomarkers

  • Major histocompatibility complex, class II, DR beta 1

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved